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Abstract
Background: Fluid bolus administration is widely recommended as part of the initial treatment of paediatric sepsis,
though the physiological benefits and harms are unclear. The primary aim of this study is to determine the effect of
fluid bolus administration on cardiac index (CI). Secondary aims are to determine the effect of fluid bolus administration
on extra-vascular lung water (EVLW), whether fluid responsiveness can be predicted by inferior vena cava (IVC)
collapsibility, and whether fluid responsiveness correlates with changes in vital signs.
Methods/design: A prospective observational study of children presenting to the Emergency Department of The
Royal Children’s Hospital with clinically diagnosed sepsis requiring fluid bolus administration. Prior to fluid bolus
administration, an echocardiogram, lung ultrasound, and IVC ultrasound will be performed, and vital signs recorded.
These will be repeated 5 min after and 60 min after fluid bolus administration. Recorded echocardiograms and lung/IVC
ultrasound will be evaluated independently by a paediatric cardiologist and paediatric emergency physician, respectively,
blinded to the patient identity and time of examination relative to time of fluid bolus administration. Fifty patients will
be enrolled in the study based on a precision based sample size calculation. Results will be analysed for change in CI
and change in EVLW 5 min after and 60 min after fluid bolus administration compared to baseline, IVC collapsibility as a
predictor of fluid responsiveness, and the relationship between fluid responsiveness and changes in vital signs.
Discussion: This study will explore assumptions about the effect of fluid boluses on CI in children with sepsis, and will
provide evidence for secondary effects on other organ systems. This may lead to novel methods for assessment and
decision making in the initial resuscitation of paediatric sepsis in clinical and research settings, and will likely influence
the design of future interventional studies in this arena.
Trial registration: The study is registered with the Australian and New Zealand Clinical Trials Registry
(ACTRN12614000824662; 04 August 2014).
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Background
Sepsis is the final common pathway and mode of death for
many paediatric infectious processes, globally accounting
for over 6 million childhood deaths per year, mostly in
underdeveloped countries [1]. Case fatality rates are
5–10 % in industrialised countries, and 20–30 % in
low and middle income countries [2, 3]. Despite being
common and serious, the therapies for the initial re-
suscitation of paediatric sepsis are based on little or
no evidence. In particular, fluid resuscitation therapy
(FRT) is widely recommended for initial sepsis resusci-
tation [4, 5], but there is limited understanding of its
potential beneficial and harmful effects, how the balance
of benefits and harms may be influenced by patient and
disease factors, and how this balance may be incorporated
into treatment guidelines for translation into clinical use.
Fluid resuscitation was initially described in patients with
severe dehydration during cholera epidemics in the early
19th century [6], and subsequently applied to trauma pa-
tients with haemorrhagic shock [7]. Both of these disease
states are characterised by intravascular volume depletion,
and replacement of this intravascular volume with the
same type of fluid that was lost helps to restore homeo-
stasis. Fluid resuscitation for sepsis was popularised in
2001, when early goal-directed therapy (EGDT) was
shown to improve survival in adults with septic shock
when instituted in the emergency department (ED) [8].
This approach involved aggressive fluid resuscitation to
achieve threshold central venous pressure (CVP) values,
followed by early initiation of vasoactive agents for on-
going hypotension, and transfusion of blood for low
central venous oxygen saturations (ScvO2). As the ini-
tial therapy in EGDT, aggressive fluid resuscitation was
the most commonly applied in practice, and the foun-
dation upon which subsequent therapies were based.
Since the publication of the EGDT protocol, the harms
from aggressive fluid resuscitation and cumulative posi-
tive fluid balance have become apparent [9–16], and
the benefit of EGDT compared to standard care has
been called into question [17–19]. In particular, the
Fluid Expansion As Supportive Therapy (FEAST) study
found that FRT in Sub-Saharan African children with
fever and signs of poor perfusion increased mortality
compared to no FRT [20]. This raises serious questions
about the role of FRT in the management of sepsis, and
our understanding of the pathophysiological mecha-
nisms underlying FRT in conditions where no volume
loss has occurred.
Aggressive FRT with the aim of increasing stroke volume,
with the assumption that this will improve end-organ per-
fusion and cellular oxygen use, may be physiologically
flawed [21]. FRT into high-capacitance veins may in
fact increase cardiac filling pressures faster than venous
pressure due to limited diastolic compliance of the
heart, thus reducing the pressure gradient driving ven-
ous return [22–24]. Increased venous pressure follow-
ing FRT may reduce the gradient driving vital organ
perfusion (MAP-CVP) [25]. Microcirculatory dysfunc-
tion through damage to the endothelial glycocalyx may
be mediated partly by natriuretic peptides released as car-
diac filling pressures increase following FRT [26–30]. The
net effect of FRT in sepsis may be that it contributes sig-
nificantly to end-organ oedema and dysfunction, and the
progression from SIRS to multi-organ dysfunction and
death [9, 10, 12, 13, 31, 32].
Limited published literature on the effect of FRT on
cardiac output (CO) suggests that any effect is modest
and transient. In a study of 20 adults with circulatory
shock, the mean increase in CO immediately following
FRT was 16 %, which decreased to 6 % above baseline
after sixty minutes [33]. In a separate study, 32 adults
with septic shock were found to have a mean increase in
CO of 15 % immediately after FRT, which returned to
3 % above baseline 40 min after FRT (p < 0.001) [34].
There is no published literature on the effect of FRT on
cardiac index (CI = CO/body surface area (BSA)) in chil-
dren. The ability to predict the response to FRT allows
the clinician to restrict this therapy only to those that
are fluid responsive. Fluid responsiveness is considered
an increase in cardiac output of 10-15 % in response to
a fluid challenge (250–500 ml in adults) [35]. In the un-
differentiated adult ICU population, as few as 50 % of
patients may be fluid responsive [35]. The remainder re-
ceive all of the potential harms from FRT with none of the
potential benefits. IVC ultrasound is a dynamic method
for assessing fluid responsiveness using cardiopulmonary
interactions [36]. In spontaneously ventilating adults, IVC
collapsibility of >40 % has been shown to be predictive of
fluid responsiveness, while IVC collapsibility of <15 % is
predictive of being fluid unresponsive [37]. No study has
validated IVC collapsibility as a predictor of fluid respon-
siveness in children.
We set out to determine the effect of FRT on CI
5 min after and 60 min after fluid bolus administration
in paediatric sepsis. Secondary aims include: the effect of
FRT on extra-vascular lung water (EVLW), whether fluid
responsiveness can be predicted by inferior vena cava
(IVC) collapsibility, and whether fluid responsiveness
correlates with changes in vital signs.
Methods/design
Study design and setting
The study is designed as a prospective observational
study of children with sepsis. It will be conducted at a
single paediatric ED in The Royal Children’s Hospital
(RCH), Melbourne, Australia. RCH is a tertiary children’s
hospital with an annual ED census of >85,000 children less
than 18 years of age.
Long et al. BMC Pediatrics  (2016) 16:93 Page 2 of 7
Inclusion and exclusion criteria
Inclusion and exclusion are listed in Table 1. Inclusion
criteria are based on international consensus definitions
for the diagnosis of sepsis in children [38].
Study procedure
Patients who fulfil the eligibility criteria and whose par-
ents provide written informed consent will be entered
into the study. Prior to administration of a standardised
fluid bolus, transthoracic echocardiography, lung and IVC
ultrasound will be performed, and vital signs recorded
(Fig. 1). Five minutes and 60 min after administration of a
standardised fluid bolus, the same measurements will be
taken. All ultrasound measurements will be taken by the
Principal Investigator (PI), who has a Post Graduate
Certificate in Echocardiography through The University
of Melbourne, Australia. Recorded echocardiograms
will subsequently be assessed by a blinded paediatric
cardiologist. Lung ultrasound and IVC ultrasound will
be assessed by a blinded paediatric emergency physician
with a Diploma in Diagnostic Ultrasound (Australian
Society for Ultrasound in Medicine). Vital signs that
will be recorded from the patients monitor (Phillips
MP70, Phillips Healthcare, Andover, MA) include: heart
rate (HR), respiratory rate (RR), blood pressure (BP), and
peripheral oxyhaemoglobin saturation (SpO2). Addition-
ally, patient temperature in degrees celcius will be re-
corded and a 10 s video recording of the patient will be
taken at each time point and used to assess conscious
state, capillary refill, and respiratory effort. These video re-
cordings will be scored in terms of Glasgow Coma Scale
for conscious state, time in seconds for capillary refill, and
Silverman Score for respiratory effort [39] by a blinded
paediatric emergency physician. Final outcomes will be




The primary outcome measure is the percentage change
in CI 5 and 60 min after standardised fluid bolus adminis-
tration compared to baseline.
Secondary outcome measures include the change in
EVLW after standardised fluid bolus administration,
whether IVC collapsibility is predictive of fluid respon-
siveness, and whether the observed change in cardiac
output following standardised fluid bolus administration
is correlated with changes in vital signs and clinical obser-
vations. We also collected the following outcome data:
ICU admission, requirement for inotrope/vasopressor infu-
sion, requirement for non-invasive or invasive ventilation,
requirement for renal replacement therapy, requirement
for extracorporeal membrane oxygenation (ECMO), final
microbiological diagnosis, and mortality.
Ultrasound techniques
Cardiac index will be measured by trans-thoracic echocar-
diography using a Zonare Z.one (Zonare Medical Systems,
Mountain View, CA, USA) and a 3–10 MHz phased array
(cardiac) transducer. An apical 5 chamber view of the heart
will be obtained and the left-ventricular outflow tract visua-
lised. A 3 mm pulsed-wave doppler sample volume will be
gated at the level of the aortic valve and the resulting wave-
form recorded. The mean velocity-time integral (VTI) over
three respiratory cycles will be recorded as the final VTI
measurement. Left-ventricular outflow tract (LVOT) diam-
eter will be measured from a parasternal long-axis (PLAX)
view in systole. Stroke volume will be calculated as (πr2) x
velocity-time integral (VTI), and CO as stroke volume
SV x HR. CI will be calculated as CO/BSA. Attempts to
minimise the impact of inter and intra-observer vari-
ability on the study results include: blinding of the ultra-
sound assessor to the patient identity and timing of the
study relative to the timing of fluid bolus administration;
and assessment of intra and inter-rater reliability between
the PI and the PI and blinded assessor, respectively, for all
ultrasound-based assessments.
Extravascular lung water will be measured on lung
ultrasound using a Zonare Z.one and an 5–14 MHz linear
array probe set at a depth of 5 cm. Eight views will be ob-
tained and recorded as described in the Fluid Administra-
tion Limited by Lung Sonography (FALLS) protocol [40].
Lung ultrasound cine-loops will be scored in a blinded
fashion for the presence of B-lines, confluent B-lines, or
complete loss of lung aeration, and used to calculate a
lung ultrasound score [41, 42].
Inferior vena cava collapsibility will be measured using
a Zonare Z.one and a 1–4 MHz curved array transducer.
A sub-costal long-axis view of the IVC will be obtained
including the IVC-right atrial (RA) junction and conflu-
ence of the hepatic veins [43]. A cine-loop recording will
Table 1 Inclusion and exclusion criteria
Inclusion criteria- all of:
Suspected infection
Temperature >38 °C or <36 °C
Systemic Inflammatory Response Syndrome
Tachycardia (temperature corrected heart rate >2 SD above
normal for agea)
or
Tachypnoea (respiratory rate >2 SD above normal for age)
Plan to administer a standardised fluid bolus by the treating
clinician
Standardised fluid bolus: 20 ml/kg of 0.9 % saline administered
via manual push/pull or pressure bag (NOT by infusion pump).
Exclusion criteria- any of:
Underlying uncorrected structural cardiac disease
Non-curative goals of therapy
Non-English speaking
aheart rate was corrected by 10 beats per minute for every degree celcius
above 38o [55]
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be taken over 3 respiratory cycles. IVC collapsibility will
be measured at the level of the hepatic veins at end-
inspiration and end expiration [44]. IVC collapsibility
will be calculated as: maximum - minimum diameter/
minimum diameter x 100.
Sample size, power, and statistical methods
For a precision based sample size estimation based on
the continuous outcome variable of change in cardiac
output following standardised fluid bolus administration,
the following assumptions have been made: a mean in-
crease in cardiac output of 20 % with a standard deviation
of 10 %, a precision of the study tool (echocardiogram)
of +/− 2 %. For a precision estimate of 5 %, a sample
size of 50 would be required. This would also allow for
regression analysis of several suspected confounding
variables, including age, underlying illness aetiology
(respiratory vs non-respiratory), and total volume of
fluid previously administered.
Limitations
Ultrasound-based assessments are user-dependent. As
such, they are prone to variability both within and between
sonographers. Ultrasound-based assessment of EVLW and
fluid responsiveness based on IVC collapsibility have been
validated in adult patients but not in children. Age-based
physiological differences in children may limit their utility
in the study population. Some vital signs recorded (such as
Fig. 1 Schedule of observations recorded during the 60 min study period. *a standardised fluid bolus was defined as 20 ml/kg of 0.9 % saline
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capillary refill, conscious state, and respiratory effort) are
qualitative and prone to bias. Efforts to minimise the im-
pact of potential bias on the study results include video re-
cording of the patient at each time point and subsequent
assessment blinded to the timing of the video recording
relative to the timing of fluid bolus administration. At the
time of assessment, enrolled patients are undifferentiated
and are being treated empirically for sepsis. They may have
an alternate final diagnosis. At the time of enrolment, pa-
tients are receiving multiple interventions, some of which
are distressing and make ultrasound assessment challen-
ging. Interventions other than fluid bolus administration
(such as the use of non-invasive or invasive ventilation, or
administration of inotropic or vaso-active therapies) may
confound the study results. To minimise the effect of other
therapies on study results, the study will focus only on the
first hour of resuscitation. Any other interventions per-
formed during the study period will be recorded. The study
will only recruit patients when the PI is available in the ED.
This limits the total number of patients recruited and the
time of day when patients are recruited.
Discussion
Four major questions remain unanswered regarding fluid
resuscitation for paediatric sepsis: what is the ideal fluid
content, what is the ideal fluid volume, over what time
period it should be administered, and what therapeutic
targets should be used to titrate therapy. This study will
help answer the questions of fluid volume and thera-
peutic targets. Current paediatric fluid resuscitation
guidelines and planned trials are based on the concept
of empiric fluid loading using vital signs as a marker of
response to treatment. This is despite evidence that the
host response to sepsis in children is highly variable and
dynamic during the disease course [45–47], and that
vital signs are a poor predictor of disease severity or re-
sponse to treatment [48–51]. As such, using a “one size
fits all” approach to fluid resuscitation seems counter-
intuitive. Alternatives include fluid responsiveness-based
FRT. Data from randomised pilot studies in adults have
shown fluid-responsiveness based resuscitation for sepsis
allows more targeted fluid resuscitation (more aggressive in
fluid responders, less aggressive in fluid non-responders),
with an overall reduction in total fluid volume administered
compared to standard treatment [52]. Additionally, the re-
sults of this study may suggest that routine assessment of
EVLW allows for both the benefits and risks of fluid resus-
citation to be included in the therapeutic equation for the
individual patient. This approach has been described but
not evaluated in randomised trials in adults [53].
This study may inform the design of future interventional
studies in paediatric sepsis. The use of fluid-responsiveness
based resuscitation limited by EVLW observed on lung
ultrasound may allow targeted and individualised treatment
[54]. This may help avoid the harms from overzealous fluid
resuscitation in some children. Such a strategy would need
to have a significant impact on patient-centred outcomes
for widespread use, due to its implications for resources,
training, and infrastructure required in ED’s caring for
children.
Abbreviations
BP, blood pressure; CI, cardiac index; CO, cardiac output; CVP, central venous
pressure; ECMO, extracorporeal membrane oxygenation; ED, emergency
department; EGDT, early goal-directed therapy; EVLW, extra-vascular lung
water; FEAST, fluid expansion as supportive therapy; FRT, fluid resuscitation
therapy; GCS, Glasgow Coma Scale; HR, heart rate; IVC, inferior vena cava; PI,
principal investigator; RCH, The Royal Children’s Hospital; RR, respiratory rate;
ScvO2, central venous oxygen saturation; SIRS, systemic inflammatory response
syndrome; SMD, septic myocardial dysfunction; SV, stroke volume
Acknowledgements
The authors would like to thank ED nursing and medical staff who have
helped identify potential patients for recruitment and helped with study
procedures. The PI would like to thank Dr Bennett Sheridan and Dr Adam
O’brien for their help with interpretation of ultrasound images.
Funding
This study was supported in part by a Shields Research Entry Scholarship,
The Royal Australasian College of Physicians, Sydney, Australia; by a National
Health and Medical Research Council Centre of Research Excellence Grant for
Pediatric Emergency Medicine (GNT1058560), Canberra, ACT, Australia; a Clinical
Sciences Theme grant, Murdoch Children’s Research Institute, Melbourne,
Australia; and the Victorian Governments Infrastructure Support Program,
Melbourne, Australia. FEB was supported in part by a grant from The Royal
Children’s Hospital Foundation.
Availability of data and materials
The dataset(s) supporting the conclusions of this article do not have ethics
approval for public use.
Authors’ contributions
All of the authors made substantial contributions to the concept and design
of the study. EL drafted the original manuscript and all authors revised it
critically. All authors have given final approval of the version to be published.
All authors have agreed to be accountable for all aspects of the work ensuring
that questions related to the accuracy or integrity of any part of the work are
appropriately investigated and resolved.
Competing interests
The authors declare that they have no competing interests.
Ethics approval and consent to participate
The study has ethics approval at the study hospital (Human Research Ethics
Committee 33169A). All parents/guardians (and patients where appropriate)
will be provided with verbal and written information about the study and
written informed consent will be obtained prior to enrolment into the study.
Author details
1Department of Emergency Medicine, The Royal Children’s Hospital, 50
Flemington Road, 3052 Parkville, VIC, Australia. 2Murdoch Children’s Research
Institute, 50 Flemington Road, Parkville, Australia. 3Department of Paediatrics,
Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne,
Victoria, Australia. 4Paediatric Intensive Care Unit, The Royal Children’s
Hospital, 50 Flemington Road, Parkville, VIC, Australia.
Received: 25 December 2015 Accepted: 9 July 2016
References
1. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P,
Campbell H, Walker CF, Cibulskis R, et al. Global, regional, and national
causes of child mortality in 2008: a systematic analysis. Lancet. 2010;
375(9730):1969–87.
Long et al. BMC Pediatrics  (2016) 16:93 Page 5 of 7
2. Watson RS, Carcillo JA. Scope and epidemiology of pediatric sepsis. Pediatr
Crit Care Med. 2005;6(3 Suppl):S3–5.
3. Jaramillo-Bustamante JC, Marín-Agudelo A, Fernández-Laverde M, Bareño-Silva J.
Epidemiology of sepsis in pediatric intensive care units: First Colombian
Multicenter Study*. Pediatr Crit Care Med. 2012;13(5):501–8. doi:10.1097/PCC.
1090b1013e31823c31980f.
4. Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A,
Davis A, Duff J, Dugas MA, et al. Clinical practice parameters for
hemodynamic support of pediatric and neonatal septic shock: 2007 update
from the American College of Critical Care Medicine. Crit Care Med. 2009;
37(2):666–88.
5. Maconochie IK, de Caen AR, Aickin R, Atkins DL, Biarent D, Guerguerian
AM, Kleinman ME, Kloeck DA, Meaney PA, Nadkarni VM, et al. Part 6:
Pediatric basic life support and pediatric advanced life support: 2015
International Consensus on Cardiopulmonary Resuscitation and
Emergency Cardiovascular Care Science with Treatment
Recommendations. Resuscitation. 2015;95:e147–68.
6. Cosnett JE. The origins of intravenous fluid therapy. Lancet. 1989;1(8641):768–71.
7. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(25):
2462–3.
8. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E,
Tomlanovich M. Early Goal-Directed Therapy in the Treatment of Severe
Sepsis and Septic Shock. N Engl J Med. 2001;345(19):1368–77.
9. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in
septic shock: a positive fluid balance and elevated central venous pressure
are associated with increased mortality. Crit Care Med. 2011;39(2):259–65.
10. Arikan AA, Zappitelli M, Goldstein SL, Naipaul A, Jefferson LS, Loftis LL. Fluid
overload is associated with impaired oxygenation and morbidity in critically
ill children. Pediatr Crit Care Med. 2012;13(3):253–8.
11. Foland JA, Fortenberry JD, Warshaw BL, Pettignano R, Merritt RK, Heard ML,
Rogers K, Reid C, Tanner AJ, Easley KA. Fluid overload before continuous
hemofiltration and survival in critically ill children: a retrospective analysis.
Crit Care Med. 2004;32(8):1771–6.
12. Rosenberg AL, Dechert RE, Park PK, Bartlett RH. Review of a large clinical
series: association of cumulative fluid balance on outcome in acute lung
injury: a retrospective review of the ARDSnet tidal volume study cohort. J
Intensive Care Med. 2009;24(1):35–46.
13. Cordemans C, De Laet I, Van Regenmortel N, Schoonheydt K, Dits H, Huber
W, Malbrain ML. Fluid management in critically ill patients: the role of
extravascular lung water, abdominal hypertension, capillary leak, and fluid
balance. Ann Intensive Care. 2012;2(Suppl 1 Diagnosis and management of
intra-abdominal hyperten):S1.
14. Micek ST, McEvoy C, McKenzie M, Hampton N, Doherty JA, Kollef MH. Fluid
balance and cardiac function in septic shock as predictors of hospital
mortality. Crit Care. 2013;17(5):R246.
15. Selewski DT, Cornell TT, Lombel RM, Blatt NB, Han YY, Mottes T,
Kommareddi M, Kershaw DB, Shanley TP, Heung M. Weight-based
determination of fluid overload status and mortality in pediatric intensive
care unit patients requiring continuous renal replacement therapy. Intensive
Care Med. 2011;37(7):1166–73.
16. Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE,
Hackbarth R, Somers MJ, Baum M, Symons JM, et al. Fluid overload and
mortality in children receiving continuous renal replacement therapy: the
prospective pediatric continuous renal replacement therapy registry. Am J
Kidney Dis. 2010;55(2):316–25.
17. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins
AM, Holdgate A, Howe BD, Webb SA, et al. Goal-directed resuscitation for
patients with early septic shock. N Engl J Med. 2014;371(16):1496–506.
18. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T,
Wang HE, Hou PC, LoVecchio F, et al. A randomized trial of protocol-based
care for early septic shock. N Engl J Med. 2014;370(18):1683–93.
19. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD,
Jahan R, Harvey SE, Bell D, Bion JF, et al. Trial of Early, Goal-Directed
Resuscitation for Septic Shock. N Engl J Med. 2015.
20. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO,
Nyeko R, Mtove G, Reyburn H, Lang T, et al. Mortality after fluid bolus in
African children with severe infection. N Engl J Med. 2011;364(26):2483–95.
21. Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ,
Van Regenmortel N. Fluid overload, de-resuscitation, and outcomes in
critically ill or injured patients: a systematic review with suggestions for
clinical practice. Anaesthesiology intensive therapy. 2014;46(5):361–80.
22. Henderson WR, Griesdale DE, Walley KR, Sheel AW. Clinical review: Guyton–
the role of mean circulatory filling pressure and right atrial pressure in
controlling cardiac output. Crit Care. 2010;14(6):243.
23. Applegate RJ, Johnston WE, Vinten-Johansen J, Klopfenstein HS, Little WC.
Restraining effect of intact pericardium during acute volume loading. Am J
Physiol. 1992;262(6 Pt 2):H1725–33.
24. Funk DJ, Jacobsohn E, Kumar A. The role of venous return in critical illness
and shock-part I: physiology. Crit Care Med. 2013;41(1):255–62.
25. Vellinga NA, Ince C, Boerma EC. Elevated central venous pressure is
associated with impairment of microcirculatory blood flow in sepsis: a
hypothesis generating post hoc analysis. BMC Anesthesiol. 2013;13:17.
26. Reitsma S, Slaaf DW, Vink H, van Zandvoort MA, oude Egbrink MG. The
endothelial glycocalyx: composition, functions, and visualization. Pflugers
Arch. 2007;454(3):345–59.
27. Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx
model of transvascular fluid exchange: an improved paradigm for
prescribing intravenous fluid therapy. Br J Anaesth. 2012;108(3):384–94.
28. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling
principle. Cardiovasc Res. 2010;87(2):198–210.
29. Ait-Oufella H, Maury E, Lehoux S, Guidet B, Offenstadt G. The endothelium:
physiological functions and role in microcirculatory failure during severe
sepsis. Intensive Care Med. 2010;36(8):1286–98.
30. Trzeciak S, Rivers EP. Clinical manifestations of disordered microcirculatory
perfusion in severe sepsis. Crit Care. 2005;9 Suppl 4:S20–6.
31. Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and
acute kidney injury. Nat Rev Nephrol. 2010;6(2):107–15.
32. Marik PE. Iatrogenic salt water drowning and the hazards of a high central
venous pressure. Ann Intensive Care. 2014;4:21.
33. Nunes TS, Ladeira RT, Bafi AT, de Azevedo LC, Machado FR, Freitas FG.
Duration of hemodynamic effects of crystalloids in patients with circulatory
shock after initial resuscitation. Ann Intensive Care. 2014;4:25.
34. Caltabeloti F, Monsel A, Arbelot C, Brisson H, Lu Q, Gu WJ, Zhou GJ, Auler JO,
Rouby JJ. Early fluid loading in acute respiratory distress syndrome with septic
shock deteriorates lung aeration without impairing arterial oxygenation: a lung
ultrasound observational study. Crit Care. 2014;18(3):R91.
35. Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid
therapy. Ann Intensive Care. 2011;1(1):1.
36. Feihl F, Broccard AF. Interactions between respiration and systemic
hemodynamics. Part I: basic concepts. Intensive Care Med. 2009;35(1):45–54.
37. Muller L, Bobbia X, Toumi M, Louart G, Molinari N, Ragonnet B, Quintard H,
Leone M, Zoric L, Lefrant JY. Respiratory variations of inferior vena cava
diameter to predict fluid responsiveness in spontaneously breathing
patients with acute circulatory failure: need for a cautious use. Crit Care.
2012;16(5):R188.
38. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus
conference: definitions for sepsis and organ dysfunction in pediatrics.
Pediatr Crit Care Med. 2005;6(1):2–8.
39. Silverman WA, Andersen DH. A controlled clinical trial of effects of water
mist on obstructive respiratory signs, death rate and necropsy findings
among premature infants. Pediatrics. 1956;17(1):1–10.
40. Lichtenstein D, Karakitsos D. Integrating lung ultrasound in the hemodynamic
evaluation of acute circulatory failure (the fluid administration limited by lung
sonography protocol). J Crit Care. 2012;27(5):533.e511–539.
41. Bouhemad B, Zhang M, Lu Q, Rouby JJ. Clinical review: Bedside lung
ultrasound in critical care practice. Crit Care. 2007;11(1):205.
42. Soummer A, Perbet S, Brisson H, Arbelot C, Constantin JM, Lu Q, Rouby JJ.
Ultrasound assessment of lung aeration loss during a successful weaning
trial predicts postextubation distress*. Crit Care Med. 2012;40(7):2064–72.
43. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial
pressure from the inspiratory collapse of the inferior vena cava.
Am J Cardiol. 1990;66(4):493–6.
44. Feissel M, Michard F, Faller JP, Teboul JL. The respiratory variation in inferior
vena cava diameter as a guide to fluid therapy. Intensive Care Med. 2004;
30(9):1834–7.
45. Deep A, Goonasekera CD, Wang Y, Brierley J. Evolution of haemodynamics
and outcome of fluid-refractory septic shock in children. Intensive Care
Med. 2013;39(9):1602–9.
46. Ranjit S, Aram G, Kissoon N, Ali MK, Natraj R, Shresti S, Jayakumar I, Gandhi D.
Multimodal monitoring for hemodynamic categorization and management of
pediatric septic shock: a pilot observational study*. Pediatr Crit Care Med. 2014;
15(1):e17–26.
Long et al. BMC Pediatrics  (2016) 16:93 Page 6 of 7
47. Brierley J, Peters MJ. Distinct hemodynamic patterns of septic shock at
presentation to pediatric intensive care. Pediatrics. 2008;122(4):752–9.
48. Scott HF, Donoghue AJ, Gaieski DF, Marchese RF, Mistry RD. Effectiveness of
physical exam signs for early detection of critical illness in pediatric systemic
inflammatory response syndrome. BMC Emerg Med. 2014;14:24.
49. Saugel B, Ringmaier S, Holzapfel K, Schuster T, Phillip V, Schmid RM, Huber W.
Physical examination, central venous pressure, and chest radiography for the
prediction of transpulmonary thermodilution-derived hemodynamic
parameters in critically ill patients: a prospective trial. J Crit Care. 2011;26(4):
402–10.
50. Nowak RM, Sen A, Garcia AJ, Wilkie H, Yang JJ, Nowak MR, Moyer ML.
The inability of emergency physicians to adequately clinically estimate the
underlying hemodynamic profiles of acutely ill patients. Am J Emerg Med.
2012;30(6):954–60.
51. Glassford NJ, Eastwood GM, Bellomo R. Physiological changes after fluid
bolus therapy in sepsis: a systematic review of contemporary data. Crit Care.
2014;18(6):696.
52. Richard J-C, Bayle F, Bourdin G, Leray V, Debord S, Delannoy B, Stoian AC,
Wallet F, Yonis H, Guerin C. Preload dependence indices to titrate volume
expansion during septic shock: a randomized controlled trial. Crit Care.
2015;19(1):5.
53. Lichtenstein D. FALLS-protocol: lung ultrasound in hemodynamic
assessment of shock. Heart, lung and vessels. 2013;5(3):142–7.
54. Marik P, Bellomo R. A rational approach to fluid therapy in sepsis.
Br J Anaesth. 2015.
55. Daymont C, Bonafide CP, Brady PW. Heart rates in hospitalized children by
age and body temperature. Pediatrics. 2015;135(5):e1173–81.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Long et al. BMC Pediatrics  (2016) 16:93 Page 7 of 7
